Table 3.
Author | Country | Patient category | CRP value (mg/L) | comment |
---|---|---|---|---|
Li et al. | China | First test | 52.9 | In 85%–100% of dead patients, CRP was found increased before death indicating that there is a high inflammatory reaction in COVID-19 patients. CRP can be a good indicator of disease progression and the decline of lymphocytes counts |
Last test | 96.2 | |||
Han et al. | China | Mild | 4.25 | CRP level was increased among poor prognostic patients |
Severe | 33.4 | |||
Wang et al. | China | Mild | 12.1 | Patients with severe disease had increased levels of CRP compared with non-severe patients. CRP was highly associated with the aggravation of non-severe COVID-19 patients, which is evidenced from regression analysis |
Severe | 43.8 | |||
Wang | Mild | 1.52 | Increased CRP levels were correlated with severe COVID-19 presentation | |
Severe | 105 | |||
Kermali et al. | United Kingdom | Mild | 33.2 | Among others, CRP showed higher levels in patients with severe COVID-19 patients compared to their non-severe counterparts |
Severe | 57.9 | |||
Pan et al. | China | Discharge | 53.5 | CRP level was found significantly correlated with death than discharged improved patients. |
Death | 85.8 | |||
Velavana et al. | Vietnam | All cases | Increased | Clinicians must consider the serum levels of CRP, which may be applicable in risk stratification to predict severe and fatal COVID-19 in admitted patients |
Severe cases | Increased | |||
Zhou et al. | China | Mild | 0.46 | CRP levels extremely varies between mild and severe COVID-19 patients |
Severe | 1.46 | |||
Luo et al. | China | Mild | 9.65 | Compared to survivors, non-survivors showed a significantly increased CRP level, and thereby identified as independent predictors of poor disease outcome. |
Severe | 100 | |||
Chen et al. | China | Mild manifestation on CT scan | 11.47 | Among others, increased CRP levels were all associated with the development of ARDS |
Moderate manifestation on CT scan | 22.94 | |||
Severe manifestation on CT scan | 34.8 | |||
Chen et al. | China | Mild | 12.47 | Higher level of plasma CRP was linearly correlated to the severity of COVID-19 disease. |
Severe | 23 | |||
Potempa et al. | United States | Non-severe | 28.7 | CRP blood levels correspond with acute phase response activation, making them a straightforward, quick, and cost-effective tool to estimate the extent of tissue damage that is occurring in that patient |
Severe | 47.6 | |||
Sadeghi-Haddad-Zavareh et al. | Iran | Non-severe | Slight increase | In severe cases, CRP levels were substantially higher than in non-severe cases. CRP could be utilized as an independent predictor in predicting the severity of COVID-19, according to an analysis of the ROC curve. |
Severe | Increased | |||
Pepys | United Kingdom | – | – | CRP has not yet been identified in COVID-19 lesions, but given the significant cell damage and amount of circulating CRP, it must be there. |
Ali et al. | Deceased (65%) | >100 | They discovered that CRP levels in deceased individuals were significantly increased, indicating hepatic impairment. | |
Recovered (6%) | ||||
Acar et al. | Turkey | Non-survivor | They concluded that inflammatory parameters, such as CRP, among others were associated with disease severity and could be used as potentially important risk factors for COVID-19 progression. | |
Survivor | ||||
Stringer et al. | United Kingdom | Dead | 115 | The most accurate predictor of death was found to be IL-6, with CRP coming in second. |
Survived | 69 | |||
Yauhen et al. | UAE | Admitted to ICU | High | Because CRP levels indicate the activity of an inflammatory process, they have a strong predictive value. |
Not admitted to ICU | Low | |||
Cui et al. | United States | Participants with Corticosteroid, low risk of death | CRP responder | Inpatient mortality may be predicted by a reduction in CRP of 50% or more within 72 h after starting corticosteroid medication. This could be used as an early indicator for COVID-19 patients’ responsiveness to corticosteroid therapy. |
Participants with Corticosteroid, high risk of death | CRP non-responder | |||
Kazemi et al. | Iran | Dead | 85.82 | There’s an association between CRP and illness severity. |
Improved | 32.99 |
CRP: C-reactive protein; CT: computed tomography; ARDS: acute respiratory distress syndrome; ROC: receiver operating characteristic; ICU: intensive care unit; UAE: United Arab Emirates.